Abstract
A prospective study was carried out to investigate acquired colour-vision deficits in diabetics using an automated, computer-controlled, cathode-ray-tube based test of chromatic contrast. Chromatic-contrast thresholds estimates were measured along both a red/green (constant S-cone) confusion axis and a tritan (constant M/L-cone) confusion axis for 305 eyes of 305 diabetics. The diabetic data were partitioned into groups based on a clinical categorisation of retinopathy. The diabetic data were compared with both age-matched and ‘lens-equated’ control data obtained from a bank of 347 normal subjects. Further analysis of differences between diabetic-status groups was performed. Associations between chromatic contrast threshold estimates and age, duration of disease, and severity of both macular oedema and ischaemia were investigated. The diabetic group was found to have significantly reduced chromatic-contrast threshold estimates when compared with normal controls, even in the absence of retinopathy. This reduction in chromatic contrast was predominantly tritanopic in nature. Interestingly, no reduction in red/green chromatic-contrast threshold estimate was found in diabetics without retinopathy. The tritan deficit seen in diabetics without retinopathy was strongly correlated with duration of disease, but when adjustments were made to account for the effects of duration-dependent lens yellowing, the tritan deficit was no longer apparent. A correlation between both the severity of macular oedema and severity of ischaemia with chromatic-contrast loss was established. Acquired reductions in both red/green and tritan chromatic-contrast threshold estimates seen in diabetics are strongly correlated with the severity of retinopathy. The results provide evidence that the specific tritan deficits seen in diabetics can be explained by the effects of lens yellowing rather than by selective damage of the blue cone system as has been hypothesised by other groups. The results provide support for the potential use of automated CRT-based tests of colour vision in diabetic retinopathy screening protocols.
Similar content being viewed by others
Article PDF
References
Zanen J . Introduction à l'étude des dyschromatopsias retiennes contrales acquises. Bull Soc Belg Ophtalmol 1953; 103: 3–148.
Dubois-Poulsen A, Cochet P . Un cas de dyschroma-topsie diabetique. Bull Soc Ophtalmol France 1954; 4: 323–30.
Cox J . Colour vision defects acquired in diseases of the eye. Br J Physiol Opt 1960; 17: 195–216.
Hong S . Types of acquired colour-vision defects. Arch Ophthalmol 1957; 58: 505–9.
Verriest G . Further studies on acquired deficiency of colour discrimination. J Opt Soc Am 1963; 53: 185–95.
Verriest G . Les déficiences acquises de la discrimination chromatique. Mem Acad R Med Belg 1964; 5: 325–7.
Kinnear PR, Aspinall PA, Lakowski R . The diabetic eye and colour vision. Trans Ophthalmol Soc UK 1972; 92: 69–78.
Lakowski R, Aspinall PA, Kinnear PR . Association between colour vision losses with diabetes mellitus. Ophthalmic Res 1972; 4: 145–9.
Trick GL, Burde RM, Gordon MO, Santiago JV, Kilo C . The relationship between hue discrimination and contrast sensitivity deficiencies in patients with diabetes mellitus. Ophthalmology 1988; 95: 693–8.
Green FD, Ghafour IM, Allan D, Barrie T, McClure E, Foulds WS . Colour vision in diabetes. Br J Ophthalmol 1985; 69: 533–6.
Lombrail P, Gervais P, Cathelineau G . Prediction of diabetic retinopathy from colour vision data. Diabetes Care 1983; 6: 621–2.
Roy MS, Gunkel RD, Podgor MJ . Colour vision defects in early diabetic retinopathy. Arch Ophthalmol 1986; 104: 225.
Roy MS, McCullough C, Hanna AK, Mortimer C . Colour vision in long standing diabetes mellitus. Br J Ophthalmol 1984; 68: 215–7.
Bresnick GH, Condit R, Palta M . Association of hue-discrimination loss and diabetic retinopathy. Arch Ophthalmol 1985; 103: 1317–24.
Utku D, Atmaca LS . Farnsworth-Munsell 100 hue test for patients with diabetes mellitus. Ann Ophthalmol 1992; 24: 205–8.
Reffin JP . The design and clinical application of tests of colour vision. DPhil Thesis, University of Sussex, Falmer, Brighton, 1992.
de Alwis DV . The role of automated chromatic contrast sensitivity tests in the management of diabetic retinopathy. MPhil Thesis, University of Sussex, Falmer, Brighton, 1994.
Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular oedema. Early Treatment Diabetic Retinopathy Study report no. 1. Arch Ophthalmol 1985; 103: 1796–806.
Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular oedema. Early Treatment Diabetic Retinopathy Study report no. 2. Ophthalmology 1987; 94: 761–4.
Tregear SJ, Knowles PJ, Ripley LG, Casswell AG . Colour vision deficits predict the development of severe diabetic retinopathy in diabetic subjects with background retinopathy. Invest Ophthalmol Vis Sci (ARVO Abstr) 1993; 34: S719.
Cornsweet TN . The staircase method in psychophysics. Am J Psychol 1962; 75: 485–91.
Lutze M, Bresnick G . Lenses of diabetic patients ‘yellow’ at an accelerated rate similar to older normals. Invest Ophthalmol Vis Sci 1991; 32: 194–9.
Moreland JD . Lens equated age controls for diabetics. Invest Ophthalmol Vis Sci 1993; 34: 281–2.
Pokorny J, Smith VC, Lutze M . Aging of the human lens. Appl Optics 1987; 26: 1437–40.
Tregear SJ, Ripley LG, Knowles PJ, Gilday RT, de Alwis DV . Automated tritan discrimination: a new clinical technique for the effective screening of severe diabetic retinopathy. Int J Psychophys 1994; 16: 191–8.
Zisman F, Adams AJ . Spectral sensitivity of cone mechanisms in juvenile diabetics. Doc Ophthalmol Proc Ser 1982; 32: 127–31.
Hardy KJ, Scarpello JHB, Foster DH, Moreland JD . Effect of diabetes associated increases in lens optical density on colour discrimination in insulin dependent diabetes. Br J Ophthalmol 1994; 78: 754–6.
Greenstein V, Sarter B, Hood D, Noble K, Carr R . Hue discrimination and s-cone pathway sensitivity in early diabetic retinopathy. Invest Ophthalmol Vis Sci 1990; 31: 1008–14.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tregear, S., Knowles, P., Ripley, L. et al. Chromatic-contrast threshold impairment in diabetes. Eye 11, 537–546 (1997). https://doi.org/10.1038/eye.1997.140
Issue Date:
DOI: https://doi.org/10.1038/eye.1997.140
Keywords
This article is cited by
-
Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2Akita diabetic mouse
Scientific Reports (2015)
-
Changes in chromatic and achromatic contrast sensitivities following tropicamide administration
Eye (2007)
-
ACE inhibition salvages the visual loss caused by diabetes
Diabetologia (2003)